These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 6502914)

  • 61. Urinary kallikrein excretion in patients with primary aldosteronism: differentiation of adrenal adenoma from idiopathic adrenal hyperplasia.
    Nakada T
    Urol Int; 1984; 39(1):40-5. PubMed ID: 6375065
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Does prolonged pretreatment with large doses of spironolactone hasten a recovery from juxtaglomerular-adrenal suppression in primary aldosteronism?
    Morimoto S; Takeda R; Murakami M
    J Clin Endocrinol Metab; 1970 Dec; 31(6):659-64. PubMed ID: 4921649
    [No Abstract]   [Full Text] [Related]  

  • 63. Abnormal urinary kallikrein in hypertension is not related to aldosterone or plasma renin activity.
    Lawton WJ; Fitz AE
    Hypertension; 1980; 2(6):787-93. PubMed ID: 7007236
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment.
    Novello M; Catena C; Nadalini E; Colussi GL; Baroselli S; Chiuch A; Lapenna R; Bazzocchi M; Sechi LA
    J Hypertens; 2007 Jul; 25(7):1443-50. PubMed ID: 17563567
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Urinary prostasin: a candidate marker of epithelial sodium channel activation in humans.
    Olivieri O; Castagna A; Guarini P; Chiecchi L; Sabaini G; Pizzolo F; Corrocher R; Righetti PG
    Hypertension; 2005 Oct; 46(4):683-8. PubMed ID: 16172430
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Non-tumorous "primary" aldosteronism. I. Type relieved by glucocorticoid (glucocorticoid-remediable aldosteronism).
    Salti IS; Stiefel M; Ruse JL; Laidlaw JC
    Can Med Assoc J; 1969 Jul; 101(1):1-10. PubMed ID: 5793351
    [No Abstract]   [Full Text] [Related]  

  • 67. Primary hyperaldosteronism without suppressed renin due to secondary hypertensive kidney damage.
    Oelkers W; Diederich S; Bähr V
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3266-70. PubMed ID: 10999820
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Plasma aldosterone concentration in patients with primary aldosteronism in the last decade].
    Nakamuta S; Muratani H; Tomita Y; Takishita S; Fujishima M; Uezono K; Kawasaki T
    Nihon Naibunpi Gakkai Zasshi; 1985 Nov; 61(11):1221-7. PubMed ID: 4092783
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Normotensive primary aldosteronism: report of a case.
    Kono T; Ikeda F; Oseko F; Imura H; Tanimura H
    J Clin Endocrinol Metab; 1981 May; 52(5):1009-13. PubMed ID: 6262353
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Increased urinary excretion of the epithelial Na channel activator prostasin in patients with primary aldosteronism.
    Pizzolo F; Chiecchi L; Morandini F; Castagna A; Zorzi F; Zaltron C; Pattini P; Chiariello C; Salvagno G; Olivieri O
    J Hypertens; 2017 Feb; 35(2):355-361. PubMed ID: 27841781
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Influence of spironolactone on serum corticosteroids in primary hyperaldosteronism.
    Abshagen U; Spörl S; Oelkers W
    Klin Wochenschr; 1979 Feb; 57(4):173-80. PubMed ID: 423483
    [No Abstract]   [Full Text] [Related]  

  • 72. [Aldosterone excretion and plasma renin activity in patients with essential hypertension and with primary aldosteronism (author's transl)].
    Helber A; Meurer KA; Rosskamp E; Wambach G; Dickmans HA; Kaufmann W
    Klin Wochenschr; 1974 Oct; 52(20):966-73. PubMed ID: 4444216
    [No Abstract]   [Full Text] [Related]  

  • 73. Activity of (des-Aspartyl1)-angiotensin II and angiotensin II in man. Differences in blood pressure and adrenocortical response during normal and low sodium intake.
    Carey RM; Vaughan ED; Peach MJ; Ayers CR
    J Clin Invest; 1978 Jan; 61(1):20-31. PubMed ID: 338631
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effect of low and high sodium diets on plasma atrial natriuretic factor, the renin-aldosterone system and blood pressure in subjects with essential hypertension.
    McKnight JA; Roberts G; Sheridan B; Atkinson AB
    Clin Endocrinol (Oxf); 1994 Jan; 40(1):73-7. PubMed ID: 8306484
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hemodynamic, renal, and hormonal responses to changes in dietary potassium in normotensive and hypertensive man: long-term antihypertensive effect of potassium supplementation in essential hypertension.
    Overlack A; Stumpe KO; Moch B; Ollig A; Kleinmann R; Müller HM; Kolloch R; Krück F
    Klin Wochenschr; 1985 Apr; 63(8):352-60. PubMed ID: 3923252
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Unilateral primary aldosteronism with spontaneous remission after long-term spironolactone therapy.
    Yoneda T; Demura M; Takata H; Kometani M; Karashima S; Yamagishi M; Takeda Y
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1109-13. PubMed ID: 22337911
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Are calcium antagonists helpful in the management of primary aldosteronism?
    Stimpel M; Ivens K; Wambach G; Kaufmann W
    J Cardiovasc Pharmacol; 1988; 12 Suppl 6():S131-4. PubMed ID: 2468897
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [A rare case of primary aldosteronism due to bilateral functioning adrenocortical adenomas].
    Yamamoto H; Sato T; Kato Y
    Nihon Naibunpi Gakkai Zasshi; 1993 Mar; 69(3):125-34. PubMed ID: 8467928
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The effect of dialysate sodium concentration on body fluid compartment volume, plasma renin activity and plasma aldosterone concentration in chronic hemodialysis patients.
    Van Stone JC; Bauer J; Carey J
    Am J Kidney Dis; 1982 Jul; 2(1):58-64. PubMed ID: 7048902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.